Uniphar plc announced the appointment of Jeffrey Berkowitz to its board as an independent non-executive director with immediate effect. Mr. Berkowitz has extensive global healthcare experience, having held senior executive positions across most key business areas in the global healthcare supply chain at UnitedHealth Group/Optum, Walgreens Boots Alliance Inc. and Merck & Co Inc. He has been recognised three times in PharmaVoice magazine as one of the 100 Most Inspiring Leaders in the Life Sciences in the past decade and was the recipient of PharmaVoice's inaugural Red Jacket Award. Jeff Berkowitz is CEO of Real Endpoints LLC, a leader in insights, supports and tools to strengthen access to pharmaceutical innovation for an evolving healthcare landscape with specific focus on value-based arrangements, patient services and access support for pharma manufacturers and payors. Mr. Berkowitz also serves on the board of directors of H. Lundbeck A/S, Esperion Therapeutics Inc., and Zealand Pharmaceuticals Inc. He is an Editorial Advisor to Life Science Leader and Pharmaceutical Commerce magazines and has previously served on the Board of Directors of the Swiss-American Chamber of Commerce. Mr. Berkowitz also serves on the board of directors of H. Lundbeck A/S, Esperion Therapeutics Inc., and Zealand Pharmaceuticals Inc. He is an Editorial Advisor to Life Science Leader and Pharmaceutical Commerce magazines and has previously served on the Board of Directors of the Swiss-American Chamber of Commerce. The company also announced that Heather Ann McSharry is stepping down from the Board with immediate effect. The company also announced the following non-executive director changes to the Committees of the Board with immediate effect: Sue Webb, Independent Non-Executive Director, has been appointed to the Audit Committee. Jeff Berkowitz and Paul Hogan, Independent Non-Executive Director, have been appointed to the Nominations Committee, with Jeff Berkowitz also appointed as Chair of the Nominations Committee; and Paul Hogan is also assuming the role of Senior Independent Director. Prior to Real Endpoints, Mr. Berkowitz served as an Executive Vice President of UnitedHealth Group/Optum, where he led Optum's International division as CEO while also driving key strategic initiatives within its pharmacy benefits management division, OptumRx. Before this, he was a member of the Executive Committee of the Walgreens Boots Alliance Inc., where he served as President of Pharma and Global Market Access. Jeff was responsible for generic and branded procurement, inventory management, relationships with pharmaceutical companies as well as the companies pricing and reimbursement strategies. He also led Walgreens specialty pharmacy business with over $10 billion in revenue and 5,800 employees. Before joining Walgreens in 2010, Mr. Berkowitz was Senior Vice President of Global Market Access for Merck & Company Inc. Mr. Berkowitz had held a similar position at Schering-Plough, where he started as legal director for Schering-Plough's managed care and commercial group in 1998. Before joining Schering, Mr. Berkowitz was a healthcare attorney for the international law firm Proskauer LLP in New York and Washington, D.C.